Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder

Trial Profile

Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Cycloserine (Primary)
  • Indications Social phobia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Feb 2017 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
    • 24 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
    • 15 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top